#news #biotech Time’s a-ticking for bankrupt Orexigen to sell off Contrave

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Time’s a-ticking for bankrupt Orexigen to sell off Contrave .Orexigen Therapeutics is filing for bankruptcy and plans to auction off its obesity med, Contrave, to pay down its debt.

from FierceBiotech: Biotech http://ift.tt/2p6KtkA